BeStock  

ANI Pharmaceuticals ANIP

US equityMarket cap rank #2847Drug Manufacturers - Specialty & Generic
$68.55 −$0.58 (-0.84%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $68.55 0.00%
Open$68.96
Prev close$69.13
Day range$68.28 – $70.20
Volume227.3K
Market cap$1.56B
P/E (TTM)13.6
Dividend yield–

Earnings

Average move on report day±7.1%last 16 reports
Closed higher10 of 1663% of the time
Best reaction+18.1%
Worst reaction-14.6%

Stock move on the day after each report

+12.3%2023/Q4+3.3%2024/Q1+7.0%2024/Q2+5.2%2024/Q3+13.4%2024/Q4-7.3%2025/Q1+18.1%2025/Q2+0.2%2025/Q3-4.2%2025/Q4-2.4%2026/Q1-5.3%2026/Q2-2.8%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q35 Nov 2026Pre Market±8.8%-2.83%Within range
2026/Q27 Aug 2026Pre Market±10.0%-5.30%Within range
2026/Q18 May 2026Pre Market±8.0%-2.44%Within range
2025/Q427 Feb 2026Pre Market±12.2%-4.21%Within range
2025/Q37 Nov 2025Pre Market±8.2%+0.22%Within range
2025/Q28 Aug 2025Pre Market±12.1%+18.07%Bigger than priced
2025/Q19 May 2025Pre Market±12.6%-7.31%Within range
2024/Q428 Feb 2025Pre Market±15.5%+13.39%Within range
2024/Q38 Nov 2024Pre Market±11.0%+5.24%Within range
2024/Q26 Aug 2024Pre Market±11.7%+6.98%Within range
2024/Q110 May 2024Pre Market±7.9%+3.29%Within range
2023/Q429 Feb 2024Pre Market±10.5%+12.26%Bigger than priced
2023/Q38 Nov 2023Pre Market±12.3%-14.64%Bigger than priced
2023/Q29 Aug 2023Pre Market±13.2%+9.21%Within range
2023/Q18 May 2023Pre Market±14.8%+8.79%Within range
2022/Q49 Mar 2023Pre Market±13.6%+0.09%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Rare Disease and Brands$182.35M 62.7%
  • Generics and Other$108.43M 37.3%

Latest reported quarter: Q3, ended Sep 2026

Revenue$290.78M+27.6% YoY
Operating profit$51.84M+127.0% YoY
Net profit$35.15M+32.1% YoY
Diluted EPS$1.51+33.6% YoY
Free cash flow$70.28M+85.5% YoY
Operating cash flow$83.79M

Revenue, last 8 quarters

$190.6MDec '24$197.1MMar '25$211.4MJun '25$227.8MSep '25$247.1MDec '25$237.5MMar '26$266.0MJun '26$290.8MSep '26

Net profit, last 8 quarters

$-10.3MDec '24$15.7MMar '25$8.5MJun '25$26.6MSep '25$27.5MDec '25$29.5MMar '26$24.7MJun '26$35.1MSep '26

Profitability & balance sheet

Gross margin61.1%
Operating margin15.3%
Net margin10.6%
Return on equity19.2%
Return on assets7.4%
Return on invested capital10.2%
Current ratio2.75
Liabilities / assets59.4%
Cash & investments$436.35M
Total debt$607.23M
Net cash (debt)-$170.88M
Free cash flow / sales19.2%

Discussion

No comments yet — be the first to weigh in on ANIP.

Sign in to join the discussion.

Scroll to Top